.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Cerilliant
Express Scripts
Cipla
McKinsey
UBS
Citi
Baxter
Merck
AstraZeneca

Generated: June 23, 2017

DrugPatentWatch Database Preview

FURADANTIN Drug Profile

« Back to Dashboard

Which patents cover Furadantin, and what generic Furadantin alternatives are available?

Furadantin is a drug marketed by Casper Pharma Llc and Procter And Gamble and is included in two NDAs.

The generic ingredient in FURADANTIN is nitrofurantoin. There are nineteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nitrofurantoin profile page.

Summary for Tradename: FURADANTIN

Patents:0
Applicants:2
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list48
Patent Applications: see list3,905
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FURADANTIN at DailyMed

Pharmacology for Tradename: FURADANTIN

Ingredient-typeNitrofurans
Drug ClassNitrofuran Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc
FURADANTIN
nitrofurantoin
SUSPENSION;ORAL009175-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
Procter And Gamble
FURADANTIN
nitrofurantoin
TABLET;ORAL008693-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Procter And Gamble
FURADANTIN
nitrofurantoin
TABLET;ORAL008693-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Federal Trade Commission
Chinese Patent Office
Covington
McKinsey
QuintilesIMS
Merck
Citi
Johnson and Johnson
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot